loader
Please Wait
Applying Filters...
menu
    • menu

    Annual Sales of Tedelparin reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

    Client Email Product
    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    Menu

    Tedelparin

    FINISHED DOSAGE FORMULATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 5Fragmin

    PharmaCompass
    Left Arrow
    Right Arrow
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Fragmin

    Dalteparin

    arrow
    Formnext Forum
    Not Confirmed

    Brand Name : Fragmin

    U.S.A
    arrow
    Formnext Forum
    Not Confirmed

    Pfizer Inc.

    Dalteparin

    Main Therapeutic Indication : Anticoagulants

    Currency : USD

    2014 Revenue in Millions : 1.40%

    2013 Revenue in Millions :

    Growth (%) :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Fragmin

    Dalteparin

    arrow
    Formnext Forum
    Not Confirmed

    Brand Name : Fragmin

    U.S.A
    arrow
    Formnext Forum
    Not Confirmed

    Pfizer Inc.

    Dalteparin

    Main Therapeutic Indication : Anticoagulants

    Currency : USD

    2015 Revenue in Millions : 364

    2014 Revenue in Millions : 335

    Growth (%) : -8%

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Fragmin

    Dalteparin

    arrow
    Formnext Forum
    Not Confirmed

    Brand Name : Fragmin

    U.S.A
    arrow
    Formnext Forum
    Not Confirmed

    Pfizer

    Dalteparin

    Main Therapeutic Indication : Blood Disorders

    Currency : USD

    2016 Revenue in Millions : 318

    2015 Revenue in Millions : 335

    Growth (%) : -5

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Fragmin

    Dalteparin

    arrow
    Formnext Forum
    Not Confirmed

    Brand Name : Fragmin

    U.S.A
    arrow
    Formnext Forum
    Not Confirmed

    Pfizer Inc.

    Dalteparin

    Main Therapeutic Indication : Blood Disorders

    Currency : USD

    2017 Revenue in Millions : 306

    2016 Revenue in Millions : 318

    Growth (%) : -4

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Fragmin

    Dalteparin

    arrow
    Formnext Forum
    Not Confirmed

    Brand Name : Fragmin

    U.S.A
    arrow
    Formnext Forum
    Not Confirmed

    Pfizer

    Dalteparin

    Main Therapeutic Indication : Blood Disorders

    Currency : USD

    2018 Revenue in Millions : 293

    2017 Revenue in Millions : 306

    Growth (%) : -4%

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF